Table 1.
Antimicrobial Category | Antimicrobial Agent | CLSI Breakpoint | EUCAST Breakpoint | Reported by Malaysian NSAR |
---|---|---|---|---|
Aminoglycosides | Gentamicin | Yes | Yes | 2005–2017 |
Ansamycins | Rifampin/rifampicin | Yes | Yes | 2005–2017 |
Anti-MRSA cephalosporins | Ceftaroline | Yes | Yes | No |
Anti-staphylococcal β-lactams (or cephamycins) | Oxacillin (or cefoxitin) | Yes | Yes | 2003–2005 |
Fluoroquinolones | Ciprofloxacin | Yes | Yes | 2007–2014 |
Moxifloxacin | Yes | Yes | No | |
Folate pathway inhibitors | Trimethoprim-sulfamethoxazole | Yes | Yes | 2005–2017 |
Fucidanes | Fusidic acid | No | Yes | 2005–2017 |
Glycopeptides | Vancomycin | Yes | Yes | 2003–2017 |
Teicoplanin | Yes | Yes | 2007–2008 | |
Telavancin | Yes | Yes | No | |
Glycylcyclines | Tigecycline | No | Yes | No |
Lincosamides | Clindamycin | Yes | Yes | 2005–2017 |
Lipopeptides | Daptomycin | Yes | Yes | No |
Macrolides | Erythromycin | Yes | Yes | 2005–2017 |
Oxazolidinones | Linezolid | Yes | Yes | 2009–2017 |
Phenicols | Chloramphenicol | Yes | Yes | 2005–2014 |
Phosphonic acids | Fosfomycin | No | Yes | No |
Streptogramins | Quinupristin-dalfopristin | Yes | Yes | 2011 |
Tetracyclines | Tetracycline | Yes | Yes | 2009–2014 |
Doxycycline | Yes | Yes | No | |
Minocycline | Yes | Yes | No |
CLSI, Clinical and Laboratories Standard Institute; EUCAST, European Committee on Antimicrobial Susceptibility Testing.